Terumo Corp. (OTCMKTS:TRUMY) Short Interest Down 74.5% in June

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a significant decline in short interest during the month of June. As of June 30th, there was short interest totaling 47,370 shares, a decline of 74.5% from the June 15th total of 185,946 shares. Based on an average daily volume of 268,986 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the company’s shares are short sold.

Terumo Stock Performance

Shares of OTCMKTS:TRUMY opened at $13.62 on Tuesday. The company has a market cap of $20.09 billion, a price-to-earnings ratio of 22.33 and a beta of 0.68. The company has a 50-day moving average price of $13.82 and a 200-day moving average price of $13.60. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06. Terumo has a 12 month low of $12.08 and a 12 month high of $19.60.

Terumo (OTCMKTS:TRUMY) last posted its earnings results on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.11. Terumo had a return on equity of 9.17% and a net margin of 12.09%.The company had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.84 billion. As a group, equities analysts anticipate that Terumo will post 0.7 EPS for the current year.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Terumo has a consensus rating of “Hold”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.